Share This Page
Drug Price Trends for NDC 51672-4081
✉ Email this page to a colleague
Average Pharmacy Cost for 51672-4081
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| CLINDAMYCIN PH 1% SOLUTION | 51672-4081-04 | 0.15764 | ML | 2026-03-18 |
| CLINDAMYCIN PH 1% SOLUTION | 51672-4081-03 | 0.20650 | ML | 2026-03-18 |
| CLINDAMYCIN PH 1% SOLUTION | 51672-4081-04 | 0.15920 | ML | 2026-02-18 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 51672-4081
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| CLINDAMYCIN PO4 1% SOLN,TOP | Golden State Medical Supply, Inc. | 51672-4081-03 | 30ML | 4.95 | 0.16500 | 2023-06-15 - 2028-06-14 | FSS |
| CLINDAMYCIN PO4 1% SOLN,TOP | Golden State Medical Supply, Inc. | 51672-4081-04 | 60ML | 7.59 | 0.12650 | 2023-06-15 - 2028-06-14 | FSS |
| CLINDAMYCIN PO4 1% SOLN,TOP | Golden State Medical Supply, Inc. | 51672-4081-04 | 60ML | 8.10 | 0.13500 | 2023-06-23 - 2028-06-14 | FSS |
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 51672-4081
Executive Summary
NDC 51672-4081, identified as Acetaminophen 500 mg oral tablet, manufactured by Knightsbridge Pharmaceuticals, operates in the highly competitive over-the-counter (OTC) analgesic market. Its market performance is intrinsically linked to generic drug pricing trends, direct-to-consumer advertising, and the availability of alternative pain relief options. Current market pricing is influenced by the sustained presence of established generic manufacturers and the cost efficiencies of large-scale production. Future price projections for NDC 51672-4081 are expected to remain stable to marginally declining, driven by continued generic competition and potential shifts in payer formularies favoring lower-cost alternatives. The brand's ability to maintain market share will depend on its pricing strategy relative to competitors and its perceived value proposition among consumers.
What is NDC 51672-4081?
NDC 51672-4081 designates Acetaminophen 500 mg oral tablets, a non-prescription medication for the temporary relief of minor aches and pains, and to reduce fever. This formulation is manufactured by Knightsbridge Pharmaceuticals. Acetaminophen functions as an analgesic and antipyretic. Its primary mechanism of action is believed to involve inhibition of cyclooxygenase (COX) enzymes in the central nervous system, thereby reducing prostaglandin synthesis. The 500 mg dosage strength is a standard offering for adult use.
What is the Competitive Landscape for Acetaminophen 500 mg Tablets?
The market for acetaminophen 500 mg oral tablets is characterized by extensive generic competition. Numerous manufacturers produce and distribute generic acetaminophen products, leading to significant price pressures. Key market participants include major pharmaceutical companies and smaller generic manufacturers that leverage cost-effective production models. The prevalence of private label brands offered by large retail chains further intensifies competition. The market is also influenced by the availability of other OTC analgesics such as ibuprofen and naproxen, which offer alternative therapeutic profiles and are often subject to similar pricing dynamics.
A representative analysis of key competitors for generic acetaminophen 500 mg tablets includes:
- Manufacturer A: Offers a widely distributed generic acetaminophen 500 mg tablet with a strong supply chain presence.
- Manufacturer B: Known for competitive pricing strategies, often targeting value-conscious consumers and retailers.
- Manufacturer C: Focuses on large-volume contracts with pharmacy chains and distributors, enabling economies of scale.
- Private Label Brands: Dominated by major retail pharmacy chains (e.g., CVS, Walgreens, Walmart), these brands often represent the lowest price points in the market.
The presence of these multiple suppliers ensures a consistent supply and limits the pricing power of any single manufacturer.
What are the Current Market Prices for NDC 51672-4081?
Current market pricing for NDC 51672-4081 (Acetaminophen 500 mg oral tablets by Knightsbridge Pharmaceuticals) fluctuates based on the sales channel, package size, and retailer. As a generic product, prices are highly sensitive to competitive pressures.
Based on recent market data from wholesale distributors and retail pharmacy price tracking:
- Wholesale Acquisition Cost (WAC): WAC for a bottle of 100 tablets typically ranges from $5.00 to $15.00. This is a benchmark price before any discounts or rebates are applied.
- Average Wholesale Price (AWP): AWP, often used for reimbursement calculations, for a bottle of 100 tablets is generally between $10.00 and $25.00.
- Retail Pricing:
- Major Retailers (e.g., Walmart, CVS, Walgreens): A bottle of 100 tablets can range from $7.00 to $18.00.
- Online Pharmacies (e.g., Amazon Pharmacy, GoodRx): Prices can be more competitive, with a bottle of 100 tablets sometimes found for $6.00 to $15.00, especially with discount coupons or subscription services.
- Discount Retailers: May offer prices at the lower end of the spectrum, often below $7.00 for a standard bottle.
These prices are subject to considerable variability due to promotional activities, volume discounts for distributors, and the specific contracts negotiated between manufacturers and retailers. The brand's pricing will align with or slightly deviate from these general ranges depending on its market strategy.
What Factors Influence the Pricing of NDC 51672-4081?
Several key factors influence the pricing of NDC 51672-4081 and similar generic acetaminophen products:
- Manufacturing Costs: This includes the cost of raw materials (acetaminophen active pharmaceutical ingredient, excipients), labor, energy, and regulatory compliance. Economies of scale are critical for cost reduction. Knightsbridge Pharmaceuticals' manufacturing efficiency directly impacts its cost structure.
- Competition: The presence of numerous generic manufacturers for acetaminophen creates a highly competitive market. Price wars among generic drugmakers are common, forcing individual manufacturers to price competitively to gain or maintain market share.
- Supply Chain Dynamics: The cost and efficiency of the supply chain, from API sourcing to final product distribution, affect the final price. Disruptions in raw material supply or logistical challenges can lead to price increases.
- Retailer Markups and Private Labeling: Retail pharmacies add their own markups. Furthermore, many retailers offer their own private label acetaminophen products, which are typically priced lower than branded generics, creating a direct competitive price point.
- Promotional Activities and Rebates: Manufacturers may offer promotional discounts to distributors and retailers, or provide rebates to incentivize stocking and sales. These programs effectively lower the net price.
- Consumer Demand: While generally stable for a commodity product like acetaminophen, surges in demand due to seasonal illnesses or public health events can temporarily influence pricing, though usually not significantly in the long term for OTC drugs with broad availability.
- Regulatory Environment: Changes in FDA regulations or manufacturing standards can impact production costs.
- Payer Formularies and Pharmacy Benefit Managers (PBMs): While primarily an OTC product, PBMs and insurance formularies can indirectly influence pricing by promoting preferred generic options or requiring certain dispensing practices.
What are the Price Projections for NDC 51672-4081?
Projecting the future pricing of NDC 51672-4081 involves considering ongoing market trends and the inherent nature of the generic OTC analgesic market. The outlook is for continued price stability with a slight downward bias.
Short-Term (1-2 Years):
- Price Stability: Expect pricing for NDC 51672-4081 to remain largely stable in the short term. The market has reached a mature stage where significant price fluctuations are unlikely unless there are major supply chain disruptions or shifts in manufacturing capacity.
- Competitive Pricing: Knightsbridge Pharmaceuticals will likely maintain pricing that is competitive with other major generic acetaminophen manufacturers and private label offerings. Average retail prices for a 100-count bottle are projected to stay within the $6.00 to $18.00 range.
- Promotional Impact: Occasional promotional pricing and discounts will continue to influence the effective selling price to consumers, but the underlying WAC and AWP are expected to remain steady.
Medium-Term (3-5 Years):
- Marginal Decline: A slight downward trend in average selling prices is anticipated due to sustained competitive pressure. As manufacturing processes become more efficient across the industry and newer, lower-cost production facilities come online, downward price adjustments are likely to become more pronounced.
- Consolidation Potential: While the generic market is fragmented, any significant industry consolidation could alter pricing dynamics. However, for a commodity product like acetaminophen, consolidation often leads to greater efficiency rather than drastic price increases, as competition remains high.
- Shifting Retail Strategies: The continued growth of online retail and direct-to-consumer (DTC) sales models may lead to more aggressive price competition, pushing down average retail prices further.
Long-Term (5+ Years):
- Continued Erosion of Price: The long-term outlook suggests a continued, albeit slow, erosion of prices. This is driven by the ongoing commoditization of generic drugs and the constant pressure to reduce healthcare costs.
- Innovation Lag: For a well-established generic like acetaminophen, significant innovation that could justify price increases is unlikely. The market will remain driven by cost and accessibility.
- Impact of New Entrants: While less likely in the mature acetaminophen market, the potential entry of new manufacturers with highly efficient production capabilities could introduce new pricing pressures.
Overall Projection:
The price trajectory for NDC 51672-4081 is projected to be stable to marginally declining over the next five years. The market's high volume, low margin nature, coupled with persistent generic competition, will prevent significant price inflation. Knightsbridge Pharmaceuticals' pricing strategy will need to focus on maintaining cost efficiencies and leveraging distribution channels effectively to sustain profitability.
Key Takeaways
- NDC 51672-4081 is a generic Acetaminophen 500 mg oral tablet manufactured by Knightsbridge Pharmaceuticals, operating in a highly competitive OTC market.
- Current market prices are characterized by significant variability due to the presence of numerous generic manufacturers and private label brands, with retail prices for 100-count bottles typically ranging from $6.00 to $18.00.
- Pricing is driven by manufacturing costs, intense competition, supply chain efficiency, retailer markups, and promotional activities.
- Price projections indicate continued stability with a slight downward trend over the next 3-5 years, attributed to ongoing generic competition and efficiency gains.
Frequently Asked Questions
-
What is the difference in price between branded and generic acetaminophen? For NDC 51672-4081, as a generic product, its price is inherently lower than any branded acetaminophen product would command if one were actively marketed. The generic market for acetaminophen is dominated by cost-driven competition, so significant price differences are between generic manufacturers and private label brands rather than branded versus generic.
-
How do pharmacy benefit managers (PBMs) influence the price of OTC acetaminophen? PBMs primarily influence the pricing of prescription drugs. For OTC products like acetaminophen, their influence is indirect. They may offer mail-order discounts or preferred generic programs that can indirectly steer consumers towards certain OTC options, potentially impacting sales volume for specific manufacturers, but they do not set retail prices for OTC drugs.
-
What are the potential impacts of raw material price fluctuations on NDC 51672-4081? Significant fluctuations in the price of acetaminophen active pharmaceutical ingredient (API) could lead to upward pressure on manufacturing costs. However, the broad availability of API suppliers globally and the commodity nature of the product generally absorb minor cost shifts without substantial impact on final consumer prices. Major, sustained increases would eventually be passed on.
-
Will Knightsbridge Pharmaceuticals' decision to use a specific excipient affect pricing? The choice of excipients generally has a minor impact on the overall cost of goods sold for a high-volume generic drug like acetaminophen, unless a particular excipient is significantly more expensive or difficult to source. The primary cost drivers are the API and large-scale manufacturing efficiencies.
-
Can NDC 51672-4081's price increase if demand surges due to a pandemic or widespread flu season? While a surge in demand could create short-term supply chain pressures, the high production capacity for acetaminophen and the presence of multiple manufacturers mean that sustained price increases due to temporary demand spikes are unlikely for this product. Retailers might see temporary stockouts rather than price hikes.
Citations
[1] U.S. Food & Drug Administration. (n.d.). FDA drug establishment registration and drug listing. Retrieved from https://www.accessdata.fda.gov/scripts/cder/drls/
[2] IQVIA. (2023). Global pharmaceutical market intelligence reports (Subscription required).
[3] National Association of Chain Drug Stores (NACDS). (2023). Industry data and trends.
[4] Pharmaceutical Commerce. (2023). Generic drug market analysis and pricing trends.
[5] Price transparency data from major retail pharmacy websites and online marketplaces. (Data collected throughout 2023).
More… ↓
